Dr. Buchanan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Spring Grove Hospital Grounds
Maple and Locust Streets
Catonsville, MD 21228Phone+1 410-402-7876Fax+1 410-402-7198
Education & Training
- George Washington UniversityResidency, Psychiatry, 1980 - 1984
- Rutgers New Jersey Medical SchoolClass of 1980
Certifications & Licensure
- MD State Medical License 1984 - 2026
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine Start of enrollment: 2001 Dec 01
- Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia Start of enrollment: 2002 May 01
- Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia Start of enrollment: 2007 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Building a two-state learning healthcare system for persons with first episode psychosis.Jill A Marsteller, Richard W Goldberg, Yasmine Boumaiz, Megan B E Jumper, Jessica Taylor
Schizophrenia Research. 2025-02-28 - Comparative Analysis of Social Cognitive and Neurocognitive Performance Across Autism and Schizophrenia Spectrum Disorders.Ayesha G Rashidi, Lindsay D Oliver, Iska Moxon-Emre, Colin Hawco, Erin W Dickie
Schizophrenia Bulletin. 2025-02-26 - Pan T cells, Helper T cells, and Regulatory T cells are Associated with Negative Symptoms in Persons with Anti-Gliadin Antibody Positive Schizophrenia and Related Diso...Deepak Salem, Sarah M Clark, Daniel J O Roche, Nevil J Singh, Monica V Talor
Medrxiv. 2025-02-25
Lectures
- Lower- and Higher-Level Social Cognitive Factors Across Individuals with Schizophrenia Spectrum Disorders and Healthy Controls: Relationship with Neurocognition and Fu...UC Davis Health System, Sacramento, California - 9/13/2012
Other
- Lower- and Higher-Level Social Cognitive Factors Across Individuals with Schizophrenia Spectrum Disorders and Healthy Controls: Relationship with Neurocognition and Fu...Robert Buchanan, MD, Schizophrenia Bulletin
https://www.doximity.com/articles/19cb6ea7-83a0-45e3-8fd1-8be0f0ddd718
UpToDate, Wolters Kluwer Health - 2011-10-10 - Lower- and Higher-Level Social Cognitive Factors Across Individuals with Schizophrenia Spectrum Disorders and Healthy Controls: Relationship with Neurocognition and Fu...Robert Buchanan, MD, Schizophrenia Bulletin
https://www.doximity.com/articles/19cb6ea7-83a0-45e3-8fd1-8be0f0ddd718
UpToDate, Wolters Kluwer Health - 2012-11-08
Press Mentions
- Polypharmacy in Psychiatry: Good, Bad, or Just Unavoidable?March 7th, 2025
- Treating Schizophrenia SuccessfullyOctober 8th, 2018
- UM SOM Professor of Psychiatry Recognized for Innovative and Promising Research in SchizophreniaOctober 31st, 2017
- Join now to see all
Grant Support
- Assessment CoreNational Institute Of Mental Health1998–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: